Key Data Highlighting Vidofludimus Calcium's Therapeutic Potential in Multiple Sclerosis Presented at 41st Congress of ECTRIMS - - Phase 2 CALLIPER Data Demonstrated ...

Fiscal 2025 net income of $271.7 million ($4.37 per diluted share) compared to $250.9 million ($4.19 per share) in fiscal 2024. Adjusted earning ...

NEW YORK, November 13, 2025 – Immunic, Inc. ( Nasdaq: IMUX), a late-stage biotechnology company pioneering the development of novel oral therapies for neurologic and gastrointestinal diseases, today ...

Valeura Energy Inc. (TSX:VLE, OTCQX:VLERF) (“Valeura” or the “Company”) reports its unaudited financial and operating results for the three and nine month periods ended September 30, 2025. Q3 ...

The following selected financial data are derived from our unaudited condensed interim consolidated financial statements and related notes thereto (the “Interim Financial Statements”) for the three ...

There's a lot of consternation among Arkansas fans about how scared they are of being left behind should there be a major ...

As the U.S. Food and Drug Administration (FDA) proposed, Clene is concluding analyses of its ALS biomarker data with completion planned shortly ...

Hole THN25-360 returned 18.50m of 3.39 g/t gold, 7.45 g/t silver, and 0.57% zinc from 90.50m depth. Including 3.00m of 15.69 ...

Cassava Sciences, Inc. (NASDAQ: SAVA, "Cassava", the "Company"), a biotechnology company focused on developing novel, investigational treatments for central nervous system (CNS) disorders such as ...

Meta Platforms delivers long-term compounding, AI monetization, strong Q3 growth and higher CAPEX with upside potential.

Robinsons Land Corporation ( OTCPK:RBLAY) Q3 2025 Earnings Call November 11, 2025 1:00 AM EST ...

The manuscript by Hensley and Yildez studies the mechanical behavior of kinesin under conditions where the z-component of the applied force is minimized. The important study shows that much of the ...